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Abstract
Background: Investigating the expression of candidate genes in tissue samples usually involves
either immunohistochemical labelling of formalin-fixed paraffin-embedded (FFPE) sections or
immunofluorescence labelling of cryosections. Although both of these methods provide essential
data, both have important limitations as research tools. Consequently, there is a demand in the
research community to be able to perform routine, high quality immunofluorescence labelling of
FFPE tissues.
Results: We present here a robust optimised method for high resolution immunofluorescence
labelling of FFPE tissues, which involves the combination of antigen retrieval, indirect
immunofluorescence and confocal laser scanning microscopy. We demonstrate the utility of this
method with examples of immunofluorescence labelling of human kidney, human breast and a tissue
microarray of invasive human breast cancers. Finally, we demonstrate that stained slides can be
stored in the short term at 4°C or in the longer term at -20°C prior to images being collected. This
approach has the potential to unlock a large in vivo database for immunofluorescence investigations
and has the major advantages over immunohistochemistry in that it provides higher resolution
imaging of antigen localization and the ability to label multiple antigens simultaneously.
Conclusion: This method provides a link between the cell biology and pathology communities.
For the cell biologist, it will enable them to utilise the vast archive of pathology specimens to
advance their in vitro data into in vivo samples, in particular archival material and tissue microarrays.
For the pathologist, it will enable them to utilise multiple antibodies on a single section to
characterise particular cell populations or to test multiple biomarkers in limited samples and define
with greater accuracy cellular heterogeneity in tissue samples.
Background
Immunohistochemistry (IHC) is one of the pillars of
modern diagnostic pathology and a fundamental research
tool in both pathology and translational research labora-
tories. Currently, labelling of FFPE specimens most com-
monly involves a biotinylated secondary antibody
followed by an avidin-biotin-peroxidase complex and
development with a soluble chromogenic substrate. This
approach is robust and reliable, and increasingly can be
automated for labelling, image acquisition and scoring.
However, as a research tool there are three major limita-
tions. First, it is primarily used to reveal one protein at a
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time; multiple colour approaches by combining peroxi-
dase with other development systems are less than satis-
factory and cannot be used to examine the co-localization
of two antigens in the same subcellular compartment. Sec-
ond, the resolution of antigen localization is limited due
to the chromogenic substrate precipitate and the thickness
(3 – 4 µm) of the sections imaged in the light microscope.
Third, chromogenic systems saturate easily, which restricts
semi-quantitative analysis. Immunofluorescence label-
ling, on the other hand, has the capability for multiple
labelling and is of higher resolution due to the fluoro-
phores being directly conjugated to the antibody. Never-
theless, immunofluorescence labelling is not often used
for FFPE specimens, the perceived mantra being that the
inherent autofluorescence of such specimens makes high
quality immunofluorescence imaging capricious. This has
placed two severe restrictions on investigators. First, it has
limited fluorescence imaging to tissue cryosections and
hence restricts analysis of clinical material. Second, as cell
and tissue preservation is lower in cryosections than in
FFPE sections, the quality of morphological findings is fre-
quently compromised. This is particularly the case in tis-
sues that are difficult to cryosection, for example cartilage,
bone and those that contain a high fat content such as the
breast. In recent years, there have been a number of
reports describing the immunofluorescence labelling of
FFPE sections [1-10] but, for a variety of reasons, these
methods have not been taken up widely by the scientific
community (see Discussion). Similarly, quantitative
immunofluorescence labelling of FFPE material, particu-
larly that in tissue microarrays, has been achieved by the
development of computer assisted fluorescence imaging
systems [11]. Although these systems have an important
role in translational research, there is still an urgent need
for a high resolution method which can be employed by
the wider research community. To this end, we have taken
a systematic approach to develop a robust protocol for
coupling antigen retrieval, indirect immunofluorescence
and confocal laser scanning microscopy to image FFPE
sections. Using this method, we demonstrate that multi-
colour immunofluorescence imaging of FFPE material is
readily achievable and that this method provides excellent
images. Of note, the data shown here were not subjected
to any image manipulation.
Results
To demonstrate the utility of this method, three examples
are provided. First, the expression of E-cadherin (cad-
herin-1), Ksp-cadherin (kidney-specific cadherin, cad-
herin-16) and collagen IV was examined in human kidney
(Figure 1 and Additional file 1). IHC analysis clearly
shows a differential labelling of the cadherins in different
tubules, each of which is surrounded by a collagen IV con-
taining basal lamina. However, with double-label
immunofluorescence the existence of 3 distinct types of
tubule (as defined by E- and Ksp-cadherin expression)
becomes apparent. In particular, such analysis shows
tubules which express neither E- nor Ksp-cadherin. Fur-
ther, the thin optical sections collected by confocal micro-
scopy demonstrate clearly that this method provides a
higher level of detail as to the subcellular distribution of
antigens. Control experiments demonstrated the specifi-
city of the secondary antibodies and the absence of back-
ground staining [see Additional file 1(2)].
In the second example, it is demonstrated that high qual-
ity 4 colour fluorescence images can be readily obtained
from archival FFPE material; in this case normal breast tis-
sue, breast tissue with columnar cell change and both duc-
tal carcinoma in situ (DCIS) and invasive components of
an oestrogen receptor (ER) positive breast cancer (Figure
2 and Additional file 1(3)). As expected in the normal
breast tissue, ER expression is limited to a subset of cytok-
eratin 8/18 (Ck 8/18) positive luminal epithelial cells and
vimentin expression is restricted to the intra- and interlob-
ular stromal fibroblasts and the vasculature with low level
staining in the myoepithelial cells. However, multicolour
confocal imaging also reveals that expression of ER in the
normal breast is associated with cells expressing high lev-
els of Ck 8/18; that there is an upregulation of vimentin
expression in the Ck 8/18 negative myoepithelial cells in
the columnar cell change [see also Additional file 1(4)];
and that scattered vimentin-positive, Ck 8/18 negative
cells admixed with neoplastic cells can be found in high
grade DCIS.
In the third example, a tissue microarray containing cores
from 245 archival invasive breast cancers [12,13] was
stained with the same antibody combination as described
above. As illustrated in Figure 3, high quality images can
be collected from these samples.
To date we have successfully employed this method with
a range of different primary and secondary antibodies on
a large number of freshly fixed and archival samples from
different normal tissues and tumour types. One perceived
limitation of immunofluorescence labelling is that
stained sections can only be stored for a short period of
time prior to collecting images. We demonstrate here that
stained slides can be stored for at least 10 weeks at 4°C or
9 months at -20°C and examined by confocal microscopy
on multiple occasions with only a negligible reduction in
the quality of images collected (Figure 4).
Discussion
We describe here an optimised method for the collection
of high quality immunofluorescence images from FFPE
sections. The first element that is key to the success of the
method is the use of a confocal microscopy has the fol-
lowing advantages over the epifluorescence microscope:BMC Cell Biology 2008, 9:13 http://www.biomedcentral.com/1471-2121/9/13
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Expression of E-cadherin, Ksp-cadherin and collagen IV in kidney Figure 1
Expression of E-cadherin, Ksp-cadherin and collagen IV in kidney. 3 µm FFPE sections of adult human kidney were 
dewaxed, rehydrated and subject to antigen retrieval. A. For immunoperoxidase labelling, sections were incubated with the 
indicated antibodies and detection was achieved with the Vectastain avidin-biotin complex (ABC) system used according to the 
manufacturer's protocol (Vector Laboratories). Slides were counterstained with haematoxylin. B. Sections were stained as 
described in the Methods with anti-E-cadherin mAb and anti-Ksp-cadherin mAb or with anti-E-cadherin mAb and anti-collagen 
IV Ab followed by Alexa488-conjugated goat anti-mouse IgG2A and Alexa555 goat anti-mouse IgG1 or Alexa488-conjugated 
goat anti-mouse IgG2A and Alexa555 goat anti-rabbit Ig. Nuclei were counterstained with DAPI. Arrows indicate tubules 
expressing both cadherins, arrowheads indicate tubules expressing neither cadherin, * indicates tubules expressing E-cadherin 
alone. Scale bar, 50 µm.BMC Cell Biology 2008, 9:13 http://www.biomedcentral.com/1471-2121/9/13
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Expression of cytokeratin 8/18, oestrogen receptor and vimentin in normal human breast and breast cancer Figure 2
Expression of cytokeratin 8/18, oestrogen receptor and vimentin in normal human breast and breast cancer. 3 
µm FFPE sections of human adult breast containing both normal tissue and columnar cell change, and an ER-positive breast can-
cer showing areas of DCIS and invasive ductal carcinoma were stained anti-Ck 8/18 mAb, anti-vimentin mAb and anti-ER Ab 
followed by Alexa488 goat anti-mouse IgG1, Alexa633 goat anti-mouse IgG2A and Alexa555 goat anti-rabbit Ig. Nuclei were 
counterstained with DAPI. In all images colours are as follows: Ck 8/18 (green), ER (red), vimentin (yellow), DAPI (blue). A. 4 
colour images, arrowheads indicate Ck 8/18-negative myoepithelial cells. B. Ck 8/18 and ER, arrows indicate ER expression in 
luminal epithelial cells with high Ck 8/18 expression in the normal breast. C. Ck 8/18 and vimentin, arrows indicate vimentin 
expression in the myoepithelial cells of columnar cell change, arrowheads indicate vimentin-positive, Ck 8/18-negative cells 
within the DCIS. D. Ck 8/18, ER and vimentin. Scale bar, 50 µm.BMC Cell Biology 2008, 9:13 http://www.biomedcentral.com/1471-2121/9/13
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Immunofluorescence labelling of tissue microarrays slides Figure 3
Immunofluorescence labelling of tissue microarrays slides. A tissue microarray containing 0.6 mm cores from 245 
invasive breast cancers was stained as described in Figure 2. Ck 8/18 (green), ER (red), vimentin (yellow), DAPI (blue). Images 
from cores of 4 invasive ductal carcinomas (IDC) and 2 invasive lobular carcinomas (ILC) are shown.BMC Cell Biology 2008, 9:13 http://www.biomedcentral.com/1471-2121/9/13
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Storage of FFPE samples after immunofluorescence labelling Figure 4
Storage of FFPE samples after immunofluorescence labelling. A. 3 µm FPPE section of columnar cell change human 
breast was stained as described in Figure 2. Images were collected directly after labelling (day 1) and again following 70 days 
storage of the stained slides at 4°C. B. 3 µm FFPE section of human kidney was stained with anti-collagen IV Ab (red) and 
mouse anti-alpha smooth muscle actin mAb (green) followed by Alexa555 goat anti-rabbit Ig and Alexa488-conjugated goat 
anti-mouse IgG2A. Nuclei were counterstained with DAPI (blue). Images were collected directly after labelling (day1) and again 
following 270 days storage of the stained slides at -20°C. Scale bar, 50 µm.BMC Cell Biology 2008, 9:13 http://www.biomedcentral.com/1471-2121/9/13
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(a) the collection of a thin (0.5 µm) optical section, whose
thickness is smaller than that of the section (3 – 4 µm),
means that the volume of the section contributing to the
autofluorescence is less, (b) a conventional mercury
vapour lamp in an epifluorescence microscope produces
light from 250–800 nm wavelength, all of which has the
potential to create autofluorescence. Laser light illumina-
tion from the confocal microscope is of a much narrower
bandwidth (<5 nm) and thus a significant amount of the
visible spectrum light is removed from the excitation
process. Furthermore, on the confocal microscope the
amount of light from each laser can be adjusted, thus cre-
ating the opportunity to minimise the excitation process
which in turn reduces autofluorescence, (c) the confocal
microscope allows the setting of numerically defined col-
lection windows, which are more precise and efficient
than the epifluorescence microscopy dichroic and trich-
roic glass filters, (d) in the confocal microscope, images
can be collected in a sequential mode, which means that
at any given time during the collection process only one
laser is exciting the tissue and only one collection window
is open. This effectively eliminates bleedthrough which
can be a significant difficulty in epifluorescence micros-
copy. The second key issue is that the new generation
AlexaFluor dyes are more stable and brighter than the pre-
vious generation of fluorescence conjugates such as fluo-
rescein isothiocyanate (FITC), rhodamine, Texas Red, Cy3
and Cy5, and their use can be tailored to the lasers availa-
ble on different confocal microscopes. The final element
of our optimised method is the implementation of careful
microscopy practises in which the individual antibodies,
the antibody combinations to be used, and the labelling
conditions are optimised prior to labelling of important
specimens. It is the combination of all these factors that
leads to the improvement in image quality described here.
In the past decade, there have been reports of immunoflu-
orescence labelling of FFPE sections from other laborato-
ries [1-10] all of which have made valuable contributions
to the field but have not been widely adopted by the sci-
entific community. At least in part, this reflects their use of
older generation fluorescence conjugates, epifluorescence
microscopes and/or complex image analysis systems. Of
particular interest have been reports that autofluorescence
can be reduced by the use of reagents such as Sudan Black
B [14,15]. As discussed here, the use of the confocal
microscope largely reduces the problem of autofluores-
cence, but it will be important in future studies to test such
reagents in the context of this method. Similarly, although
we demonstrate here that immunofluorescent labelling of
FFPE sections is at least as sensitive as IHC labelling using
the Vectastain avidin-biotin complex (ABC) system from
Vector Laboratories (Figure 1) or the EnVision+ System-
HRP from Dako (data not shown), future studies will be
required to assess the sensitivity compared to the new gen-
eration of amplification systems such as HRP polymers.
Conclusion
In conclusion, this method helps to bridge a gap between
classical IHC of FFPE material, immunofluorescence
labelling of fresh frozen material and high throughput
systems for FFPE immunofluorescence detection. The
ability to collect routinely high quality multicolour
images from FFPE sections using a confocal microscopy
combines the advantages of labelling material which is
morphologically well preserved with the ability to study
co-expression of multiple markers and to detect subcellu-
lar antigen localization within tissue samples. It is often
difficult to know the orientation of the tissue within a fro-
zen sample and to locate the desired area for analysis. This
can only be determined by cutting a cryosection and
counterstaining with haematoxylin and eosin. Following
trimming and reorientation of the block, this process has
to be repeated until the material is correctly positioned,
and as a consequence is a time consuming and tedious
process. As FFPE blocks routinely have a haematoxylin
and eosin stained reference section, these can be used to
select the block best suited for the investigation prior to
employing the immunofluorescence labelling method
described here. Therefore this method can be employed as
an efficient research tool to utilise the vast and invaluable
archive of FFPE tissues for more detailed cell biology anal-
ysis.
Methods
Full detail of the protocol we have used is provided below,
together with suggestions for optimising the method for
individual users. Antibodies used in this study are detailed
in Table 1.
Protocol: Starting material
Starting material is formalin-fixed paraffin embedded
(FFPE) tissues. For this, tissue is fixed in 10% neutral buff-
ered formalin (Bios Europe, Lancashire, UK) overnight at
room temperature, then processed using a Tissue-Tek VIP
automatic tissue processor (Sakura, Finland) with a stand-
ard 14 hour protocol and embedded into paraffin wax
(Tissue-Tek). 3–4 µm sections are cut from the embedded
blocks and floated onto a warm (42°C) water bath from
where they are picked up onto Superfrost plus slides (Cat
No 631–0108, VWR International, Lutterworth, Leicester-
shire, UK). Slides are placed in a vertical rack and dried
overnight at 37°C in a fan assisted cabinet. The next day,
slides are dated and placed in a container which is then
purged with oxygen-free nitrogen gas (BOC gases, Guild-
ford, Surrey, UK). The containers are stored at 4°C. To
carry out a labelling experiment, the required slides are
removed and the container with remaining slides is againBMC Cell Biology 2008, 9:13 http://www.biomedcentral.com/1471-2121/9/13
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purged with oxygen-free nitrogen gas before replacing at
4°C.
Notes on slide storage
DiVito and colleagues [16] have investigated the long
term preservation of antigenicity on tissue microarrays,
and their preferred method of storage is to recoat the cut
sections with paraffin wax and store the slides under
nitrogen gas. We adopted this method, but did not find
any easily discernible difference in image quality when
labelling slides that have been left uncoated on the bench
for up to a month compared to those that have been wax
coated and stored under nitrogen gas (data not shown). At
present, we routinely store cut sections uncoated under
nitrogen gas, but we would advise individual investigators
to test the optimal storage conditions for their samples
and antibodies.
Protocol: Dewaxing and antigen retrieval
Slides are loaded into glass slide holders and dewaxed as
follows: Twice in 100% xylene (Fisher Scientific, Lough-
borough, Leicestershire, UK) for 5 minutes with 10 sec-
onds agitation every 30 seconds, 100% ethanol (BDH,
Poole, Dorset, UK) with 10–20 seconds agitation, once in
90% ethanol with 10–20 seconds agitation, once with
70% ethanol with 10–20 seconds agitation and twice in
H2O with 10–20 seconds agitation. The rack is transferred
into 200 ml of pre-warmed (94°C–96°C) Dako (Ely,
Cambridgeshire, UK) target retrieval solution (S1699, 20
ml of stock into 180 ml H2O) in a glass container in the
water bath which is set at 95°C. Antigen retrieval is 30
minutes in the water bath, 20 minutes on the bench and
5 minutes in running water.
Notes on dewaxing and antigen retrieval
It is essential that the slides are completely dewaxed
before labelling. For some uncoated slides, xylene treat-
ment may have to be increased to 2 × 10 minutes. For
slides that have been recoated in wax, we recommend 2 ×
20 minutes incubation in xylene. As with immunohisto-
chemical labelling, it is also important for each investiga-
tor to first establish the antigen retrieval method best
suited to the combination of antibodies to be used. In the
experiments described here, robust labelling with all anti-
bodies is achieved using the Dako target retrieval solution.
Protocol: Immunofluorescence labelling
Slides are removed from the running water and wiped
around the section to create an 'island' onto which 100 –
200  µl of phosphate buffered saline (PBS) is carefully
added to prevent the section from drying out. Next an
ImmEdge pen (H-4000, Vector Laboratories, Peterbor-
ough, UK) is used to 'ring' the 'island'. The slide is shaken
to remove excess PBS and 200 µl of immunofluorescence
buffer (IFF) (PBS plus 1% bovine serum albumin (A3059,
Sigma, Poole, Dorset, UK) and 2% foetal calf serum (Inv-
itrogen, Paisley, UK), filtered through a 0.2 µm filter) is
carefully pipetted onto the section before placing the
slides in a moist chamber at room temperature. All fol-
lowing incubations are at room temperature with gentle
mixing on a rocking platform, except where the primary
antibody is applied overnight in which case the incuba-
tion is at 4°C (without rocking). Details of all antibodies
used are in Table 1. Primary antibody(s) diluted in IFF for
60 minutes (or overnight at 4°C), 3 × 5 minute washes in
PBS, 2 µg/ml secondary antibody diluted in IFF for 60
minutes, 3 × 5 minute washes in PBS containing 1.43 µM
4',6-diamidino-2-phenylindole (DAPI; D21490, Invitro-
gen,). The volumes used throughout are 100 – 200 µl
depending on the size of the section.
Table 1: List of antibodies, suppliers and concentrations used
Antigen Isotype Suppliers Concentration
E-cadherin mouse IgG2A BD Biosciences, #610181 (Oxford, UK) 0.25 µg/ml
Ksp-cadherin mouse IgG1 Zymed, clone 4H6/F9, #18–7383 (InVitrogen) 0.4 µg/ml
collagen IV rabbit polyclonal Acris, #R1041 (Herford, Germany) 5.0 µg/ml
Ck 8/18 mouse IgG1 Novocastra, clone 5D3, #5D3CE (Newcastle upon Tyne, UK) 0.94 µg/ml
vimentin mouse IgG2A Dako, clone Vim 3B4, #M7020 0.25 µg/ml
ER rabbit polyclonal Labvision, clone SP1, #RM-9101-S1 (Runcorn, Cheshire, UK) 1:400
αSMA mouse IgG2A Sigma, #A2547 clone 1A4 0.88 µg/ml
Second layer antibody Company Concentration
Alexa488-conjugated goat anti-mouse IgG2A Invitrogen, #A21131 2.0 µg/ml
Alexa488-conjugated goat anti-mouse IgG1 Invitrogen, #A21121 2.0 µg/ml
Alexa555-conjugated goat anti-mouse IgG1 Invitrogen, #A21127 2.0 µg/ml
Alexa555-conjugated goat anti-rabbit Ig Invitrogen, #A21429 2.0 µg/ml
Alexa633-conjugated goat anti-mouse IgG2A Invitrogen, #A21136 2.0 µg/mlBMC Cell Biology 2008, 9:13 http://www.biomedcentral.com/1471-2121/9/13
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Slides are rinsed in PBS, mounted in Vectashield (H-1000,
Vector Laboratories) and sealed with clear nail varnish.
This is best achieved by placing 8 µl of Vectashield on a 22
× 40 mm coverslip (0.155 – 0.185 mm thickness, VWR
International), lowering the coverslip onto the section
and gently squeezing out the excess Vectashield before
sealing with nail varnish. Stained slides are stored at 4°C.
We routinely collect images from slides within 0–5 days
after labelling. High quality images can be collected fol-
lowing storage at 4°C for up to 10 weeks (see Figure 4A).
However, if it is envisaged that the slides will be examined
at later times, we strongly recommend storage at -20°C.
As shown in Figure 4B, we have collected images follow-
ing storage of slides at -20°C for 9 months with minimal
loss in quality. Our recommendation is to collect images
from slides that have been stored at -20°C within 1 – 4
weeks.
Notes on antibody concentration, multiple labelling and 
controls
In the majority of experiments, AlexaFluor-conjugated
secondary antibodies (Molecular Probes, Invitrogen) were
used. However, successful results have also been obtained
with FITC-conjugated antibodies (data not shown).
As with immunofluorescence labelling of fresh or parafor-
maldehyde fixed samples, optimal results are obtained by
first determining the optimal antibody concentration to
be used. We routinely do this by titrating the antibody in
double dilutions (e.g. 1:50, 1:100, 1:200 and so forth)
and finding the lowest dilution that gives strong specific
labelling with the low background labelling (i.e. the opti-
mal signal:noise ratio). In conjunction, we check that our
routine 60 min labelling at room temperature is optimal
for each antibody. If necessary, a longer labelling period
and/or labelling at 4°C can be used. In this study all of the
secondary antibodies employed were AlexaFluor conju-
gates supplied as a stock concentration of 2 mg/ml. Dou-
bling dilution experiments on FFPE sections indicates that
2 µg/ml is the optimal concentration for all secondary
antibodies. In these optimisation experiments, it is of par-
amount importance to have predefined positive and neg-
ative controls.
The order in which primary and secondary antibodies are
added depends on the antibody combinations to be
employed. In the examples shown in this manuscript, pri-
mary antibodies are mixed together at the appropriate
dilution in IFF and added to the section. Following the
PBS washes, the different secondary antibodies (each at 2
µg/ml) are added together to the sections. In other exper-
iments, we have successfully performed sequential label-
ling; for example, incubation of sections with primary
mouse monoclonal antibody (mAb), wash in PBS, incu-
bation with Alexa555-conjugated anti-mouse Ig second-
ary antibody, wash in PBS, incubation with FITC-
conjugated mouse mAb (data not shown). Whatever
labelling combination is employed, it is essential to con-
duct control experiments to ensure that there is no anti-
body cross reactivity. For example, in the experiments
shown in Figure 1B, a mouse mAb IgG2A is used to detect
E-cadherin and a mouse mAb IgG1 is used to detect Ksp-
cadherin. As control experiments [see Additional file
1(2)], each primary mAb is replaced in turn with the same
concentration of antibody from the same species (in this
case mouse IgG) to confirm that the anti-mouse IgG1 sec-
ondary antibody does not recognise the primary IgG2A
mAb and that the anti-mouse IgG2A secondary antibody
does not recognise the primary IgG1 mAb.
Protocol: Confocal microscopy
The stained sections are visualised with a Leica SP2 confo-
cal scanning microscope (Leica Microsystems, Milton Key-
nes, Bucks, UK) set up with the laser outputs controlled
via the Acousto-Optical Tunable Filter and the four collec-
tion windows using the Acousto-Optical Beam Splitter as
follows; 403 nm laser (25%) window 410–483 nm, 488
nm laser (25%) window 493–538 nm, 543 nm laser
(100%) window 548–628 nm and 633 nm laser (25%)
window 638–700 nm. Images are collected using the
microscope in sequential mode with a line average of 4
and a format of 1024 × 1024 pixels. We routinely collect
images using a ×20 dry lens (lens specification,
HCPLAPOCS NA 0.7; Leica) at ×1 zoom or with a ×40 oil
immersion lens (lens specification, HCXPLAPO NA 1.25;
Leica) with immersion oil (518F, Zeiss, Welwyn Garden
City, Hertfordshire. UK) at ×1 or × 2 zoom. Images are
exported from the Leica confocal software into Adobe
Photoshop CS2 v.9. In the figures shown in this manu-
script, there was no image manipulation performed prior
to export into Adobe Illustrator CS2 v12 to generate the
figures.
Abbreviations
Ck, cytokeratin; DAPI, 4',6-diamidino-2-phenylindole;
DCIS, ductal carcinoma in situ; ER, oestrogen receptor;
FFPE, formal-fixed paraffin-embedded; Ig, immunoglob-
ulin; IHC, immunohistochemistry; FITC, fluorescein iso-
thiocyanate; IFF, immunofluorescence buffer; mAb,
monoclonal antibody; PBS, phosphate buffered saline;
SMA, smooth muscle actin.
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